DAX24.217 +1,0%ESt505.379 +0,8%Top 10 Crypto15,90 -2,1%Dow44.642 -0,4%Nas21.093 -0,4%Bitcoin101.764 +0,1%Euro1,1553 -0,3%Öl72,67 +3,2%Gold3.324 +0,3%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Novo Nordisk A3EU6F NVIDIA 918422 Rheinmetall 703000 Heidelberger Druckmaschinen 731400 RENK RENK73 Lufthansa 823212 Volkswagen (VW) vz. 766403 Tesla A1CX3T PayPal A14R7U Deutsche Bank 514000 Mercedes-Benz Group (ex Daimler) 710000 BASF BASF11 DroneShield A2DMAA Amazon 906866 HENSOLDT HAG000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX schließt deutlich im Plus -- Wall Street tiefer -- PayPal mit starkem Ergebnis -- D-Wave, Novo Nordisk, Uniper, UnitedHealth, Heidelberger Druckmaschinen, TeamViewer, Hypoport, Tilray im Fokus
Top News
Rekordlaune mit Risiko: Warum Anleger bei Bitcoin jetzt wachsam bleiben sollten Rekordlaune mit Risiko: Warum Anleger bei Bitcoin jetzt wachsam bleiben sollten
Warum sich der Euro zum US-Dollar stabilisiert Warum sich der Euro zum US-Dollar stabilisiert
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Ãœbersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Deutscher Zertifikatepreis 2025: Jetzt abstimmen und attraktive Preise gewinnen!

Durect Aktie

Handeln
Durect Aktien-Sparplan
1,62 EUR +1,15 EUR +241,77 %
STU
1,87 USD ±0,00 USD ±0,00 %
nachbörslich
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.14,85 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA3DZZ2

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS2666055007

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolDRRX

Durect Aktien News

DatumMeistgelesen
PR NewswireBausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
PR NewswireDURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update
PR NewswireDURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Wer­bungDurect-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireDURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update
PR NewswireDURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
PR NewswireDURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence
PR NewswireDURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million
PR NewswireDURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update
PR NewswireDURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update
PR NewswireDURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024
PR NewswireDURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis
PR NewswireDURECT Corporation to Present at the H.C. Wainwright Global Investment Conference
PR NewswireDURECT Corporation Reports Second Quarter 2024 Financial Results and Business Update
PR NewswireDURECT Corporation to Announce Second Quarter 2024 Financial Results and Provide a Business Update
PR NewswireDURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis
PR NewswireDURECT Corporation Reports First Quarter 2024 Financial Results and Business Update
PR NewswireDURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update
PR NewswireDURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis
PR NewswireDURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PR NewswireDURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update
PR NewswireDURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada
PR NewswireDURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
PR NewswireDURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update
PR NewswireDURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business Update
PR NewswireDURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis with Promising Effect on Mortality
PR NewswireDURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis
PR NewswireDURECT Corporation Announces Presentations in Upcoming Investor Conferences
PR NewswireDURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update
PR NewswireDURECT Corporation to Announce Second Quarter 2023 Financial Results and Provide a Business Update
PR NewswireDURECT Completes Enrollment in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis
PR NewswireDURECT Corporation Reports First Quarter 2023 Financial Results and Business Update
PR NewswireDURECT Corporation to Announce First Quarter 2023 Financial Results and Provide Business Update on May 8
PR NewswireDURECT Corporation to Host KOL Event on Alcohol-Associated Hepatitis
PR NewswireDURECT Corporation to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference
PR NewswireDURECT Corporation Announces Appointment of Gail Maderis as Chair of the Board
PR NewswireDURECT Corporation Fireside Chat at the Oppenheimer 33rd Annual Healthcare Conference
PR NewswireDURECT Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and AHFIRM Trial Update
PR NewswireDURECT Corporation to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 7

Durect News

Durect News: auf dieser Seite finden Sie alle Durect News und Nachrichten zur Durect Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Durect News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Durect News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.